Broken redirects

The following redirects link to non-existent pages:

Showing below up to 50 results in range #831 to #880.

831. EMIP-FR → European Myocardial Infarction Project—Free Radicals
832. E-SIRIUS → European Sirolimus-Eluting Stent In Coronary Lesions
833. ESHRE → European Society of Human Reproduction and Embryology
834. EURO-SPAH → European Sonotherapy Trial To Prevent Arterial Hyperplasia
835. ESPS2 → European Stroke Prevention Study 2
836. ESPS-2 → European Stroke Prevention Study 2
837. ESTAT → European Stroke Treatment With Ancrod Trial
838. EUTOPIA → European Trial On Olmesartan And Pravastatin In Inflammation And Atherosclerosis
839. EUROPA → European Trial On Reduction Of Cardiac Events With Perindopril In Stable Coronary Artery Disease
840. ELECT → Evaluating Enoxaparin (Lovenox) Clotting Times
841. EPIC → Evaluation Of C7E3 For The Prevention Of Ischemic Complications
842. EDGE → Evaluation Of Daptomycin (Cidecin) In Gram-Positive Entities
843. EDGECAP → Evaluation Of Daptomycin (Cidecin) In Gram-Positive Entities In The Treatment Of Community-Acquired Pneumonia
844. EDGESST → Evaluation Of Daptomycin (Cidecin) In Gram-Positive Entities In The Treatment Of Complicated Skin And Soft Tissue Infections
845. EDGEUTI → Evaluation Of Daptomycin (Cidecin) In Gram-Positive Entities In The Treatment Of Complicated Urinary Tract Infection
846. A to Z, Phase Z → Evaluation Of Early Versus Delayed Initiation Of Simvastatin In Patients Who Receive Guideline Based Treatment For Acute Coronary Syndrome
847. ELITE → Evaluation Of Losartan In The Elderly
848. ENCORE I → Evaluation Of Nifedipine And Cerivastatin On Recovery Of Coronary Endothelial Function
849. EPISTENT → Evaluation Of Platelet IIb/IIia Inhibitor For Stenting Trial
850. EPILOG → Evaluation Of Ptca To Improve Long-Term Outcome By C7E3 Gp IIb/IIia Receptor (Abciximab) Blockade
851. ERASER → Evaluation Of Reopro And Stenting To Eliminate Restenosis
852. ESCAMI → Evaluation Of The Safety And Cardioprotective Effects Of Eniporide In Acute Myocardial Infarction
853. ETHECC → Evaluation Of Thymitaq In Hepatocellular Carcinoma
854. EVIDENCE → Evidence For Interferon Dose-Effect: European-North American Comparative Efficacy Study (Rebif V. Avonex In Relapsing-Remitting Multiple Sclerosis (Rrms))
855. Biological evolution → Evolution
856. Evolved → Evolution
857. Theory of evolution → Evolution
858. Evolutionary → Evolution
859. Darwinian evolution → Evolution
860. Evolve → Evolution
861. Evolutionary theory of sex → Evolution of sex
862. Ewan Cameron (Vitamin C) → Ewan Cameron (physician)
863. MOXCON → Excess Mortality In Chf Patients Treated With Sr Moxonidine Leads To Study Termination: Results Of The Sr Moxonidine For Congestive Heart Failure Trial
864. ERBAC → Excimer Laser, Rotational Atherectomy, Balloon Angioplasty Complications Study
865. ELVD-CHF → Exercise In Left Ventricular Dysfunction And Chronic Heart Failure Trial
866. ETICA → Exercise Training Intervention After Coronary Angioplasty: The Etica Trial
867. Expectation maximization → Expectation-maximization algorithm
868. PEPAF → Experimental Program For Physical Activity Promotion
869. Hyper-Cerebral Electrosis → Exploding head
870. EXCLAIM → Extended Clinical Prophylaxis In Acutely Ill Medical Patients (Lovenox (Enoxaparin) Postmarketing (Phase Iv) Trial)
871. ELATE → Extended Low-Intensity Anticoagulation For Thrombo-Embolism Investigators
872. EXCITe → Extremity Constraint-Induced Therapy
873. EASE → Ezetimibe Add-On To Statin Therapy For Effectiveness Trial
874. FINESSE → Facilitated Intervention With Enhanced Reperfusion Speed To Stop Events
875. Choking game → Fainting game
876. Familial benign hypocalciuric hypercalcemia → Familial Hypocalciuric hypercalcemia
877. Vitamin E familial isolated, deficiency of → Familial isolated vitamin e deficiency
878. FRISC → Fast Revascularization During Instability In Coronary Artery Disease
879. Fast Food → Fast food
880. FAAT → Fatty Acid Antiarrhythmia Trial